CoreQuest Sagl is a pharmaceutical company conducting research and development of pharmaceutical products and medical devices in nephrology and surgical areas. It develops biocompatible hypertonic solutions for peritoneal dialysis, designs devices and monitoring techniques for dialysis patients, and pursues research programs addressing chronic renal failure and congestive heart failure, including a peritoneal ultrafiltration platform (Polycore).
AI-generated
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Industry:Research & DevelopmentMedical Technology IndustryPharmaceutical Industry
✓ Offered5
Research and development of pharmaceutical products and medical devices
Research and development of pharmaceutical products and medical devices in nephrology and surgery, with identification of new therapeutic targets, preclinical pharmacology, engineering and prototyping.
Biocompatible hypertonic solutions for peritoneal dialysis
Low-glucose hypertonic solutions for peritoneal dialysis, with osmo-metabolic ingredients, reduced peritoneal toxicity and support for patients with chronic renal failure.
Therapeutic platform for congestive heart failure
Therapeutic platform based on peritoneal ultrafiltration with Polycore, to promote fluid removal, preserve renal and peritoneal function and reduce the impact of glucose.
Medical devices and monitoring techniques for dialysis patients
Design and development of new medical devices and monitoring techniques to improve the quality of life of dialysis patients.
Pre-competitive transfer and development of research programmes
Development of research programmes up to the pre-competitive industrial development stage, with commercial licence agreements, co-development and transfer with pharmaceutical and biomedical companies.
Knowledge
No knowledge articles yet
Once CoreQuest Sagl has claimed this profile, we'll publish editorial articles and case studies here together.